Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial
- DOI
- 10.1128/aac.00984-26
- Published
- 2026-09-04
- Container
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1128/aac.00984-26,
title = {Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial},
author = {Yuming Guo and Yonggang Li and Pan Zhao and Jingfeng Bi and Chaoyun Gou and Zhengran Chuai and Shuangjie Yu and Renjie Zhang and Jinfa Du and Yi Ou and Ruonan Xu and Na Guo and Fu-Sheng Wang and Yuanyuan Li},
year = {2026},
journal = {Antimicrobial Agents and Chemotherapy},
doi = {10.1128/aac.00984-26},
url = {https://doi.org/10.1128/aac.00984-26}
}RIS
TY - JOUR TI - Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial AU - Yuming Guo AU - Yonggang Li AU - Pan Zhao AU - Jingfeng Bi AU - Chaoyun Gou AU - Zhengran Chuai AU - Shuangjie Yu AU - Renjie Zhang AU - Jinfa Du AU - Yi Ou AU - Ruonan Xu AU - Na Guo AU - Fu-Sheng Wang AU - Yuanyuan Li PY - 2026 JO - Antimicrobial Agents and Chemotherapy DO - 10.1128/aac.00984-26 UR - https://doi.org/10.1128/aac.00984-26 ER -
APA
Guo, Y., Li, Y., Zhao, P., Bi, J., Gou, C., Chuai, Z., Yu, S., Zhang, R., Du, J., Ou, Y., Xu, R., Guo, N., Wang, F., & Li, Y. (2026). Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00984-26
Source records
- crossref · retrieved 2026-09-26T23:12:56.446Z